Yangonin Blocks Tumor Necrosis Factor-α-Induced Nuclear Factor-κB-Dependent Transcription by Inhibiting the Transactivation Potential of the RelA/p65 Subunit

The nuclear factor-κB (NF-κB) transcription factors control many physiological processes including inflammation, immunity, and apoptosis. In our search for NF-κB inhibitors from natural resources, we identified yangonin from Piper methysticum as an inhibitor of NF-κB activation. In the present study...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Ma (Author), He Liang (Author), Hong Ri Jin (Author), Nguyen Tien Dat (Author), Shan Yu Zhang (Author), Ying Zi Jiang (Author), Ji Xing Nan (Author), Donghao Li (Author), Xue Wu (Author), Jung Joon Lee (Author), Xuejun Jin (Author)
Format: Book
Published: Elsevier, 2012-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8a8e4d46e231438d9c673334d3d26511
042 |a dc 
100 1 0 |a Juan Ma  |e author 
700 1 0 |a He Liang  |e author 
700 1 0 |a Hong Ri Jin  |e author 
700 1 0 |a Nguyen Tien Dat  |e author 
700 1 0 |a Shan Yu Zhang  |e author 
700 1 0 |a Ying Zi Jiang  |e author 
700 1 0 |a Ji Xing Nan  |e author 
700 1 0 |a Donghao Li  |e author 
700 1 0 |a Xue Wu  |e author 
700 1 0 |a Jung Joon Lee  |e author 
700 1 0 |a Xuejun Jin  |e author 
245 0 0 |a Yangonin Blocks Tumor Necrosis Factor-α-Induced Nuclear Factor-κB-Dependent Transcription by Inhibiting the Transactivation Potential of the RelA/p65 Subunit 
260 |b Elsevier,   |c 2012-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1254/jphs.11215FP 
520 |a The nuclear factor-κB (NF-κB) transcription factors control many physiological processes including inflammation, immunity, and apoptosis. In our search for NF-κB inhibitors from natural resources, we identified yangonin from Piper methysticum as an inhibitor of NF-κB activation. In the present study, we demonstrate that yangonin potently inhibits NF-κB activation through suppression of the transcriptional activity of the RelA/p65 subunit of NF-κB. This compound significantly inhibited the induced expression of the NF-κB-reporter gene. However, this compound did not interfere with tumor necrosis factor-α (TNF-α)-induced inhibitor of κBα (IκBα) degradation, p65 nuclear translocation, and DNA-binding activity of NF-κB. Further analysis revealed that yangonin inhibited not only the induced NF-κB activation by overexpression of RelA/p65, but also transactivation activity of RelA/p65. Moreover, yangonin did not inhibit TNF-α-induced activation of p38, but it significantly impaired activation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase. We also demonstrated that pretreatment of cells with this compound prevented TNF-α-induced expression of NF-κB target genes, such as interleukin 6, interleukin 8, monocyte chemotactic protein 1, cyclooxygenase-2 and inducible nitric oxide. Taken together, yangonin could be a valuable candidate for the intervention of NF-κB-dependent pathological conditions such as inflammation. Keywords:: yangonin, nuclear factor-κB (NF-κB), RelA/p65, transactivation, inflammation 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 118, Iss 4, Pp 447-454 (2012) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319305389 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/8a8e4d46e231438d9c673334d3d26511  |z Connect to this object online.